Drug stocks gain; Athersys soars for second day
December 22, 2009 at 10:52 AM EST
BOSTON (MarketWatch) -- Drug stocks advanced early Tuesday as shares of Athersys Inc. soared for the second day following news it has entered into a collaboration with Pfizer Inc. for its stem-cell therapy MultiStem.